Investor mix
5 investors on record; lead investors include Edmond de Rothschild, Sofinnova Partners, Inno Bio Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Private equity | 1 | 20% |
| Bank & private debt | 2 | 40% |
Developer of therapeutics for the treatment of neurological and psychiatric diseases
5 investors on record; lead investors include Edmond de Rothschild, Sofinnova Partners, Inno Bio Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Private equity | 1 | 20% |
| Bank & private debt | 2 | 40% |